Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000898430-02-002685
Filing Date
2002-07-26
Accepted
2002-07-26 14:01:51
Documents
6
Period of Report
2002-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 696995
3 AMENDED ARTICLES OF INCORPORATION dex3ai.htm EX-3.(A)(I) 4874
4 STOCK OPTION AGREEMENT 8/23/01 (2,000,000 SHARES) dex4m.htm EX-4.(M) 7933
5 STOCK OPTION AGREEMENT 8/23/01 (3,500,000 SHARES) dex4n.htm EX-4.(N) 7888
6 STOCK OPTION AGREEMENT 12/3/01 dex4o.htm EX-4.(O) 7600
7 STOCK OPTION AGREEMENT 3/1/02 dex4p.htm EX-4.(P) 8046
  Complete submission text file 0000898430-02-002685.txt   735833
Mailing Address 2685 CULVER AVE SUITE 400 KETTERING OH 45429
Business Address 2685 CULVER AVE KETTERING OH 45429 9372986070
SYNTHETIC BLOOD INTERNATIONAL INC (Filer) CIK: 0000034956 (see all company filings)

EIN.: 223067701 | State of Incorp.: NJ | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 002-31909 | Film No.: 02711865
SIC: 8731 Services-Commercial Physical & Biological Research